Diffractive Trifocal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bausch + Lomb Will Present New Scientific Data And Analyses On Products And Pipeline Programs During The Association For Research In Vision And Ophthalmology Meeting
News provided by
Share this article
One Podium Presentation and 11 Poster Presentations to be Featured
LAVAL, QC, April 29, 2021 /PRNewswire/  Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ( Bausch Health ), today announced the presentation of new scientific data and clinical analyses, including one podium presentation and 11 poster presentations, during the virtual Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place from May 1-7, 2021. The virtual presentations will feature several of the company s prominent products from its pharmaceutical, surgical and vision care portfolios, as well as data from the company s ongoing Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) surveillance ....

United States , Lainie Keller , Joe Gordon , Edof Iols Xie , Arthur Shannon , Bausch Health Companies Inc , Drug Administration , Clearside Biomedical Inc , Exchange Commission , Bausch Lomb Incorporated , Association For Research , Bausch Health , One Podium Presentation , Bausch Health Companies , Antibiotic Resistance Monitoring , Clearside Biomedical , Diffractive Trifocal , Ophthalmic Viscosurgical Device , Enhanced Hydroxyl Radical Scavenging Activity , Longitudinal Antibiotic Susceptibility Trends , Clinical Suprachoroidal Injection Experience , Non Infectious Uveitis , Suprachoroidal Injection Procedure Utilizing , Three Retinal Disorders , Vitro Potency , Antibiotic Resistance ,